Healthcare & Life Sciences

Nightstar Therapeutics

United Kingdom

acquired

Stage

About

Nightstar Therapeutics was a clinical-stage biotechnology company developing gene therapies for inherited retinal disorders and other hereditary vision-loss conditions, primarily using AAV-based approaches to deliver corrective genes to the retina.

Explore Nightstar Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.